ISSCR News
Stem Cell Reports Named Official Conference Journal for “Latest Advances in Stem Cell-Based Disease Modelling and Drug Screening”
The meeting takes place in Copenhagen, Denmark, 23-24 April 2026
The International Society for Stem Cell Research (ISSCR) announces that Stem Cell Reports, its official open-access, peer-reviewed journal published by Cell Press, has been named the official conference journal for the upcoming meeting, Latest Advances in Stem Cell-Based Disease Modelling and Drug Screening, taking place 23-24 April, 2026, in Copenhagen, Denmark.
The ISSCR Launches New Continuing Education Course on Stem Cell Therapies for Parkinson’s Disease
The International Society for Stem Cell Research (ISSCR) today announced the launch of Stem Cell Medicine: Parkinson’s Disease, a new continuing education course designed to equip clinicians with an evidence-based understanding of emerging stem cell therapies for Parkinson’s disease (PD).
Building on the success of the Society’s inaugural course, Stem Cell Medicine: From Scientific Research to Patient Care, this disease-focused program provides physicians and other healthcare professionals with deeper insight into how advances in stem cell science are moving toward clinical application in one of the most intensively studied neurological disorders.
Cloaked Stem Cells Evade Immune Rejection in Mice, Pointing to a Potential Universal Donor Cell Line
A study published today in Stem Cell Reports demonstrates that genetically engineered human pluripotent stem cells (hPSCs) can overcome immune rejection in mice with humanized immune systems, surviving for five months in a stringent transplantation model. The findings provide proof-of-principle for the development of a potential universal donor hPSC line designed to resist immune attack.
mRNA Therapy Restores Fertility in Genetically Infertile Mice
Researchers have found that targeted delivery of messenger RNA (mRNA) can restore sperm production and fertility in genetically infertile male mice. The findings, published today in Stem Cell Reports, demonstrate that transient mRNA treatment restored sperm production and enabled the birth of healthy offspring.
The ISSCR Honors Alexander Meissner with the 2026 ISSCR Momentum Award for Exceptional Work in Developmental and Stem Cell Epigenetics
The International Society for Stem Cell Research (ISSCR) is pleased to announce that Alexander Meissner, Director at the Max Planck Institute for Molecular Genetics, Germany, has been named the recipient of the 2026 ISSCR Momentum Award. The award, supported by BlueRock Therapeutics, recognizes an investigator whose sustained scientific contributions continue to shape and accelerate the field of stem cell research. Dr. Meissner will present his work during ISSCR 2026 taking place in Montréal, Canada on 8-11 July 2026.
Receive ISSCR Press Releases
Sign up be a part of ISSCR’s media list. Media Contact: Kym Kilbourne, Director of Media and Strategic Communications
Subscribe to ISSCR News.
Each month, ISSCR delivers scientific, policy, and community to your inbox .